EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mannose-Functionalized Chitosan-TPGS/Tween 80 Nanocarriers for Macrophage Targeting: Enhanced Piperine Delivery to Potentiate Anti-Inflammatory and Antioxidant Therapy

Abdullah Mohammed Ayedh Al Adhreai, Johnson Retnaraj Samuel Selvan Christyraj iD, Prathiba Gnanasekaran, Hemanth P K Sudhani, Haorongbam Joldy Devi iD, Yumnam Asha Devi iD, Maharshi Bhaswant iD

Antioxidants · 28.04.2026 · 15 (5) · 559

DOI: 10.3390/antiox15050559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 28.04.2026. Verfasst von Abdullah Mohammed Ayedh Al Adhreai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Regeneration and Stem Cell Biology Lab, Centre for Molecular and Nanomedical Sciences, International Research Centre, Sathyabama Institute of Science…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Piperine (PIP), a plant alkaloid with anti-inflammatory and antioxidant effects, has poor solubility and bioavailability, limiting its therapeutic potential in macrophage-mediated inflammatory and oxidative stress conditions. Despite various nanocarrier systems being explored for bioactive compounds, the specific combination of mannose-functionalized chitosan with dual stabilizers (TPGS and Tween 80) for enhanced macrophage targeting and piperine delivery has not been investigated. We hypothesized that this novel formulation would significantly enhance piperine solubility, macrophage uptake, and anti-inflammatory/antioxidant effects compared to conventional systems, while modulating apoptosis-related pathways. This study evaluated targeted and non-targeted nanoparticles synthesized by ionic gelation and emulsification using RAW 264.7 and THP-1 macrophages. FTIR, UV–Vis, XRD, and CHNS confirmed mannose conjugation, while SEM, TEM, and AFM revealed morphology. Physicochemical properties were assessed by DLS, encapsulation efficiency (EE%), drug loading (DL%), and stability. Biological evaluations included drug release, cytotoxicity (MTT), apoptosis analysis (Annexin V–FITC/PI staining), cellular uptake (fluorescence microscopy with coumarin-6), anti-inflammatory assays (extracellular and intracellular NO inhibition, cytokine suppression), antioxidant activity (DPPH, ABTS, FRAP, TAC), intracellular ROS/RNS, and apoptosis-related markers. Targeted nanoparticles showed larger mean size (162 nm) versus non-targeted ones (78 nm). EE% was 82% (targeted) and 92% (non-targeted). Both demonstrated sustained 72 h release. Cellular uptake was significantly greater for targeted nanoparticles. Both formulations reduced NO and pro-inflammatory cytokines, regulated apoptosis-associated markers, and induced controlled apoptosis at higher concentrations, with stronger effects observed for targeted particles. Antioxidant activity increased dose-dependently, with targeted nanoparticles showing superior intracellular ROS/RNS suppression. This novel multi-functional platform efficiently encapsulates PIP, enhances macrophage targeting, modulates apoptosis pathways, and demonstrates superior therapeutic promise for inflammation-related disorders.

Schlagwörter

Stichwörter der Autor:innen

TPGS/Tween 80 stabilizationanti-inflammatory activityantioxidant propertiesmacrophage-targeted deliverymannosylated chitosan nanoparticlespiperine nanodelivery

Autor:innen und Institutionen

  • Regeneration and Stem Cell Biology Lab, Centre for Molecular and Nanomedical Sciences, International Research Centre, Sathyabama Institute of Science and Technology, Chennai 600119, Tamil Nadu, India.
  • Department of Microbiology, Sathyabama Dental College and Hospital, Chennai 600119, Tamil Nadu, India.
  • School of Biosciences and Technology, SRM Institute of Science and Technology, Tiruchirappalli Campus, Tiruchirappalli 621105, Tamil Nadu, India.

ORCID-Profile: Johnson Retnaraj Samuel Selvan Christyraj, Haorongbam Joldy Devi, Yumnam Asha Devi, Maharshi Bhaswant

Zitieren

APA

Ayedh Al Adhreai, A. M., Christyraj, J. R. S. S., Gnanasekaran, P., Sudhani, H. P. K., Devi, H. J., Devi, Y. A., & Bhaswant, M. (2026). Mannose-Functionalized Chitosan-TPGS/Tween 80 Nanocarriers for Macrophage Targeting: Enhanced Piperine Delivery to Potentiate Anti-Inflammatory and Antioxidant Therapy. Antioxidants, 15(5), 559. https://doi.org/10.3390/antiox15050559

Vancouver

Ayedh Al Adhreai AM, Christyraj JRSS, Gnanasekaran P, Sudhani HPK, Devi HJ, Devi YA, et al. Mannose-Functionalized Chitosan-TPGS/Tween 80 Nanocarriers for Macrophage Targeting: Enhanced Piperine Delivery to Potentiate Anti-Inflammatory and Antioxidant Therapy. Antioxidants. 2026;15(5):559. doi:10.3390/antiox15050559

BibTeX
@article{AyedhAlAdhreai2026,
  author = {Ayedh Al Adhreai, Abdullah Mohammed and Christyraj, Johnson Retnaraj Samuel Selvan and Gnanasekaran, Prathiba and Sudhani, Hemanth P K and Devi, Haorongbam Joldy and Devi, Yumnam Asha and Bhaswant, Maharshi},
  title = {Mannose-Functionalized Chitosan-TPGS/Tween 80 Nanocarriers for Macrophage Targeting: Enhanced Piperine Delivery to Potentiate Anti-Inflammatory and Antioxidant Therapy},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {559},
  doi = {10.3390/antiox15050559}
}
Kostenlos starten →